These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8120505)

  • 1. Cost benefit analysis of Haemophilus influenzae type b vaccination programme in Israel.
    Ginsberg GM; Kassis I; Dagan R
    J Epidemiol Community Health; 1993 Dec; 47(6):485-90. PubMed ID: 8120505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccination in India.
    Clark AD; Griffiths UK; Abbas SS; Rao KD; Privor-Dumm L; Hajjeh R; Johnson H; Sanderson C; Santosham M
    J Pediatr; 2013 Jul; 163(1 Suppl):S60-72. PubMed ID: 23773596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of Haemophilus influenzae type b disease in Australia and an economic appraisal of the vaccine PRP-OMP.
    Harris A; Hendrie D; Bower C; Payne J; de Klerk N; Stanley F
    Med J Aust; 1994 Apr; 160(8):483-8. PubMed ID: 8170423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The costs and benefits of a vaccination programme for Haemophilus influenzae type B disease.
    Hussey GD; Lasser ML; Reekie WD
    S Afr Med J; 1995 Jan; 85(1):20-5. PubMed ID: 7784909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-benefit analysis of haemophilus influenzae type B immunization in Korea.
    Shin S; Shin YJ; Ki M
    J Korean Med Sci; 2008 Apr; 23(2):176-84. PubMed ID: 18436997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-benefit analysis of Haemophilus influenzae type b vaccination in children in Spain.
    Jiménez FJ; Guallar-Castillón P; Rubio Terrés C; Guallar E
    Pharmacoeconomics; 1999 Jan; 15(1):75-83. PubMed ID: 10345159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-benefit analysis of general vaccination against Haemophilus influenzae type b in Sweden.
    Trollfors B
    Scand J Infect Dis; 1994; 26(5):611-4. PubMed ID: 7855559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of general childhood vaccination against Haemophilus influenzae type b in Sweden.
    Garpenholt O; Silfverdal SA; Levin LA
    Scand J Infect Dis; 1998; 30(1):5-10. PubMed ID: 9670351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules.
    Miller MA; McCann L
    Health Econ; 2000 Jan; 9(1):19-35. PubMed ID: 10694757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian Federation.
    Platonov AE; Griffiths UK; Voeykova MV; Platonova OV; Shakhanina IL; Chistyakova GG; Robertson SE;
    Vaccine; 2006 Mar; 24(13):2367-76. PubMed ID: 16413949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya.
    Akumu AO; English M; Scott JA; Griffiths UK
    Bull World Health Organ; 2007 Jul; 85(7):511-8. PubMed ID: 17768499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia.
    Gessner BD; Sedyaningsih ER; Griffiths UK; Sutanto A; Linehan M; Mercer D; Mulholland EK; Walker DG; Steinhoff M; Nadjib M
    Pediatr Infect Dis J; 2008 May; 27(5):438-43. PubMed ID: 18398383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of Haemophilus influenzae type b vaccine in Vietnam.
    Le P; Griffiths UK; Anh DD; Franzini L; Chan W; Swint JM
    Vaccine; 2015 Aug; 33(36):4639-46. PubMed ID: 26044493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of Haemophilus influenzae type b conjugate vaccine program in Florida.
    Midani S; Ayoub EM; Rathore MH
    J Fla Med Assoc; 1995 Jun; 82(6):401-2. PubMed ID: 7643054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran.
    Teimouri F; Kebriaeezadeh A; Zahraei SM; Gheiratian M; Nikfar S
    Daru; 2017 Jan; 25(1):1. PubMed ID: 28088246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An economic analysis of alternatives for childhood immunisation against Haemophilus influenzae type b disease.
    McIntyre P; Hall J; Leeder S
    Aust J Public Health; 1994 Dec; 18(4):394-400. PubMed ID: 7718653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The cost-effectiveness of Haemophilus influenzae type b vaccine for children under 2 years of age in Colombia].
    Alvis Guzmán N; De La Hoz Restrepo F; Vivas Consuelo D
    Rev Panam Salud Publica; 2006 Oct; 20(4):248-55. PubMed ID: 17316483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness evaluation of vaccination against Haemophilus influenzae invasive diseases in France.
    Livartowski A; Boucher J; Detournay B; Reinert P
    Vaccine; 1996 Apr; 14(6):495-500. PubMed ID: 8782346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of treatment and prevention of Haemophilus influenzae type b disease. An international perspective.
    Clements DA
    Pharmacoeconomics; 1994 Nov; 6(5):442-52. PubMed ID: 10161247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of Haemophilus influenzae type B vaccination in Indonesia: a cost-effectiveness analysis.
    Broughton EI
    J Public Health (Oxf); 2007 Dec; 29(4):441-8. PubMed ID: 17875589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.